The STAT3/ARG1 pathway also contributes to the suppression of CD8+ T cells induced by MDSCs in MDS; the use of STAT3 inhibitors can partially restore the CD8+ T cell function interfered by the MDSCs derived from MDS [62]. The gene discussed is STAT3; the disease is myelodysplastic syndrome.